98 related articles for article (PubMed ID: 29624022)
1. Simvastatin modulates β-catenin/MDR1 expression on spheres derived from CF41.Mg canine mammary carcinoma cells.
Cruz P; Reyes F; Torres CG
Pol J Vet Sci; 2018 Mar; 21(1):95-99. PubMed ID: 29624022
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
Torres CG; Olivares A; Stoore C
Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
[TBL] [Abstract][Full Text] [Related]
3. Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells.
Serrano C; Guzmán S; Arias JI; Torres CG
BMC Vet Res; 2019 Nov; 15(1):390. PubMed ID: 31684950
[TBL] [Abstract][Full Text] [Related]
4. Effect of Melatonin on Chemoresistance Exhibited by Spheres Derived from Canine Mammary Carcinoma Cells.
Cataldo D; Aravena G; Escobar A; Tapia JC; Peralta OA; Torres CG
Animals (Basel); 2024 Apr; 14(8):. PubMed ID: 38672378
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β-catenin signaling pathway after spinal cord injury.
Gao K; Shen Z; Yuan Y; Han D; Song C; Guo Y; Mei X
J Neurochem; 2016 Jul; 138(1):139-49. PubMed ID: 26443048
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin and lovastatin, but not pravastatin, interact with MDR1.
Sakaeda T; Takara K; Kakumoto M; Ohmoto N; Nakamura T; Iwaki K; Tanigawara Y; Okumura K
J Pharm Pharmacol; 2002 Mar; 54(3):419-23. PubMed ID: 11902809
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin.
Atil B; Berger-Sieczkowski E; Bardy J; Werner M; Hohenegger M
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):17-32. PubMed ID: 26319048
[TBL] [Abstract][Full Text] [Related]
9. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of expression of the Wnt signaling components in canine mammary tumors via RT
Yu F; Rasotto R; Zhang H; Pei S; Zhou B; Yang X; Jin Y; Zhang D; Lin D
J Vet Sci; 2017 Sep; 18(3):359-367. PubMed ID: 27586466
[TBL] [Abstract][Full Text] [Related]
11. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
12. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of stem cell markers by simvastatin in 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast cancer.
Rennó AL; Alves-Júnior MJ; Rocha RM; De Souza PC; de Souza VB; Jampietro J; Vassallo J; Hyslop S; Anhê GF; de Moraes Schenka NG; Soares FA; Schenka AA
Toxicol Pathol; 2015 Apr; 43(3):400-10. PubMed ID: 25341428
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells.
Kobayashi K; Baba K; Kambayashi S; Okuda M
Vet Comp Oncol; 2021 Mar; 19(1):99-108. PubMed ID: 32779819
[TBL] [Abstract][Full Text] [Related]
15. Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling.
Diao H; Cheng N; Zhao Y; Xu H; Dong H; Thamm DH; Zhang D; Lin D
BMC Vet Res; 2019 Aug; 15(1):276. PubMed ID: 31375107
[TBL] [Abstract][Full Text] [Related]
16. Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway.
Zhang ZM; Wu JF; Luo QC; Liu QF; Wu QW; Ye GD; She HQ; Li BA
Oncogene; 2016 Sep; 35(36):4787-97. PubMed ID: 26876203
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
[TBL] [Abstract][Full Text] [Related]
18. Expression of beta-catenin, E-cadherin and APC in canine mammary tumors.
Restucci B; Maiolino P; Martano M; Esposito G; De Filippis D; Borzacchiello G; Lo Muzio L
Anticancer Res; 2007; 27(5A):3083-9. PubMed ID: 17970048
[TBL] [Abstract][Full Text] [Related]
19. Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expression.
Gracanin A; Timmermans-Sprang EP; van Wolferen ME; Rao NA; Grizelj J; Vince S; Hellmen E; Mol JA
PLoS One; 2014; 9(6):e98698. PubMed ID: 24887235
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of cancer stem cells in canine mammary tumors.
Rybicka A; Król M
Acta Vet Scand; 2016 Dec; 58(1):86. PubMed ID: 27993142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
